154 related articles for article (PubMed ID: 38869826)
1. Aberrant protein aggregation in amyotrophic lateral sclerosis.
Wang H; Zeng R
J Neurol; 2024 Jun; ():. PubMed ID: 38869826
[TBL] [Abstract][Full Text] [Related]
2. Connecting RNA-Modifying Similarities of TDP-43, FUS, and SOD1 with MicroRNA Dysregulation Amidst A Renewed Network Perspective of Amyotrophic Lateral Sclerosis Proteinopathy.
Pham J; Keon M; Brennan S; Saksena N
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422969
[TBL] [Abstract][Full Text] [Related]
3. Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS.
Tsekrekou M; Giannakou M; Papanikolopoulou K; Skretas G
Front Mol Biosci; 2024; 11():1383453. PubMed ID: 38855322
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis.
Prasad A; Bharathi V; Sivalingam V; Girdhar A; Patel BK
Front Mol Neurosci; 2019; 12():25. PubMed ID: 30837838
[TBL] [Abstract][Full Text] [Related]
5. The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.
Kalmar B; Lu CH; Greensmith L
Pharmacol Ther; 2014 Jan; 141(1):40-54. PubMed ID: 23978556
[TBL] [Abstract][Full Text] [Related]
6. "STRESSED OUT": The role of FUS and TDP-43 in amyotrophic lateral sclerosis.
Aksoy YA; Deng W; Stoddart J; Chung R; Guillemin G; Cole NJ; Neely GG; Hesselson D
Int J Biochem Cell Biol; 2020 Sep; 126():105821. PubMed ID: 32758633
[TBL] [Abstract][Full Text] [Related]
7. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
[TBL] [Abstract][Full Text] [Related]
8. TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic target.
Ojaimi YA; Dangoumau A; Alarcan H; Hergesheimer R; Vourc'h P; Corcia P; Lanznaster D; Blasco H
Expert Opin Ther Targets; 2022 Jun; 26(6):575-592. PubMed ID: 35652285
[TBL] [Abstract][Full Text] [Related]
9. Using yeast models to probe the molecular basis of amyotrophic lateral sclerosis.
Bastow EL; Gourlay CW; Tuite MF
Biochem Soc Trans; 2011 Oct; 39(5):1482-7. PubMed ID: 21936838
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology.
Ince PG; Highley JR; Kirby J; Wharton SB; Takahashi H; Strong MJ; Shaw PJ
Acta Neuropathol; 2011 Dec; 122(6):657-71. PubMed ID: 22105541
[TBL] [Abstract][Full Text] [Related]
11. Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients.
Sproviero D; La Salvia S; Giannini M; Crippa V; Gagliardi S; Bernuzzi S; Diamanti L; Ceroni M; Pansarasa O; Poletti A; Cereda C
Front Neurosci; 2018; 12():487. PubMed ID: 30072868
[TBL] [Abstract][Full Text] [Related]
12. The prion-like nature of amyotrophic lateral sclerosis.
McAlary L; Yerbury JJ; Cashman NR
Prog Mol Biol Transl Sci; 2020; 175():261-296. PubMed ID: 32958236
[TBL] [Abstract][Full Text] [Related]
13. Metals in ALS TDP-43 Pathology.
Koski L; Ronnevi C; Berntsson E; Wärmländer SKTS; Roos PM
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830074
[TBL] [Abstract][Full Text] [Related]
14. Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis.
Smethurst P; Risse E; Tyzack GE; Mitchell JS; Taha DM; Chen YR; Newcombe J; Collinge J; Sidle K; Patani R
Brain; 2020 Feb; 143(2):430-440. PubMed ID: 32040555
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-183-5p regulates TAR DNA-binding protein 43 neurotoxicity via SQSTM1/p62 in amyotrophic lateral sclerosis.
Kim HC; Zhang Y; King PH; Lu L
J Neurochem; 2023 Mar; 164(5):643-657. PubMed ID: 36527420
[TBL] [Abstract][Full Text] [Related]
16. Prion-like Mechanism in Amyotrophic Lateral Sclerosis: are Protein Aggregates the Key?
Lee S; Kim HJ
Exp Neurobiol; 2015 Mar; 24(1):1-7. PubMed ID: 25792864
[TBL] [Abstract][Full Text] [Related]
17. Shared Molecular Mechanisms in Alzheimer's Disease and Amyotrophic Lateral Sclerosis: Neurofilament-Dependent Transport of sAPP, FUS, TDP-43 and SOD1, with Endoplasmic Reticulum-Like Tubules.
Muresan V; Ladescu Muresan Z
Neurodegener Dis; 2016; 16(1-2):55-61. PubMed ID: 26605911
[TBL] [Abstract][Full Text] [Related]
18. TDP-43/FUS in motor neuron disease: Complexity and challenges.
Guerrero EN; Wang H; Mitra J; Hegde PM; Stowell SE; Liachko NF; Kraemer BC; Garruto RM; Rao KS; Hegde ML
Prog Neurobiol; 2016; 145-146():78-97. PubMed ID: 27693252
[TBL] [Abstract][Full Text] [Related]
19. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
20. Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS.
Soo KY; Halloran M; Sundaramoorthy V; Parakh S; Toth RP; Southam KA; McLean CA; Lock P; King A; Farg MA; Atkin JD
Acta Neuropathol; 2015 Nov; 130(5):679-97. PubMed ID: 26298469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]